References
- Alsop K, Fereday S, Meldrum C, et al (2012). BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian ovarian cancer study group. J Clin Oncol, 30, 2654-63. https://doi.org/10.1200/JCO.2011.39.8545
- Clark SL, Rodriguez AM, Snyder RR, (2012). Structure-Function Of The Tumor Suppressor BRCA1. Comput Struct Biotechnol J. Research Network Computational Structural Biotechnol, 1, 1-8.
- De La Hoya M, Sulleiro S, Osorio A, et al (2002). Clustering of cancer-related mutations in a subset of BRCA1 alleles: A study in the Spanish population. Int J Cancer, 100, 618-9. https://doi.org/10.1002/ijc.10527
- Haiman CA, Stram DO, Pike MC, et al (2003). A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet, 12, 2679-92. https://doi.org/10.1093/hmg/ddg294
- Forat-Yazdi M, Neamatzadeh H, Sheikhha MH, et al (2015). BRCA1 and BRCA2 common mutations in Iranian breast cancer patients: a meta-analysis. Asian Pac J Cancer Prev, 16, 1219-24. https://doi.org/10.7314/APJCP.2015.16.3.1219
- Friedenson B (2005). BRCA1 and BRCA2 Pathways and the risk of cancers other than breast or ovarian. Med Gen Med, 7, 60.
- Laitman Y, Feng B-J, Zamir IM, et al (2012) Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet. Nature Publishing Group, 21, 212-6.
- Mefford HC, Baumbach L, Panguluri RC, et al (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet, 65, 575-8. https://doi.org/10.1086/302511
- Miresmaeili M, Kordi D M, Kalantar M, Moshtaghioun M (2016) Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer. Int J Reprod BioMed, 14, 271-4 https://doi.org/10.29252/ijrm.14.4.271
- Neamatzadeh H, Shiryazdi SM, Kalantar SM (2015). BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review. J Res Med Sci, 20, 284-93.
- Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, et al (2008). Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer: Original Article. Pathol Int, 58, 275-81. https://doi.org/10.1111/j.1440-1827.2008.02223.x
- Osorio A, de la Hoya M, Rodriguez-Lopez R, et al (2003). Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. Eur J Hum Genet, 11, 489-92. https://doi.org/10.1038/sj.ejhg.5200969
- Ticha I, Kleibl Z, Stribrna J, et al (2012). Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat, 124, 337-47.
- Walsh T, Casadei S, Coats KH, et al (2006). Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 295, 1379-88. https://doi.org/10.1001/jama.295.12.1379